Podcast Episodes

Back to Search
Episode 326 ASCO24: KIM-1 in Renal Cancer
Episode 326 ASCO24: KIM-1 in Renal Cancer

Season 3

Laurence Albiges discusses this circulating biomarker which may be predictive and prognostic.

2 years, 4 months ago

Short Long
View Episode
Episode 325 ASCO24: KN426 and the CLEAR trial - tissue based biomarkers for kidney cancer
Episode 325 ASCO24: KN426 and the CLEAR trial - tissue based biomarkers for kidney cancer

Season 3

Toni Choueiri and Brian describe similarities and differences in the biomarker findings of these two trials. Debate about the value and future of thi…

2 years, 4 months ago

Short Long
View Episode
Episode 324 ASCO24: SURE1 neoadjuvant sacituzumab govitecan in UC
Episode 324 ASCO24: SURE1 neoadjuvant sacituzumab govitecan in UC

Season 3

Andrea Necchi gives us the lowdown of efficacy and toxicity of this combination.

2 years, 4 months ago

Short Long
View Episode
Episode 323 ASCO24: TDXD in Bladder Cancer
Episode 323 ASCO24: TDXD in Bladder Cancer

Season 3

Jonathan Rosenberg gets to grips with the data available for the bladder cohort from the TDXD Destiny pan-tumour cohort.

2 years, 4 months ago

Short Long
View Episode
Episode 322 ASCO24: The role of ctDNA in the TheraP trial (LuPSMA vs cabazitaxel in CRPC)
Episode 322 ASCO24: The role of ctDNA in the TheraP trial (LuPSMA vs cabazitaxel in CRPC)

Season 3

Alex Wyatt describes the predictive resistance of ctDNA fraction at baseline in predicting outcome.

2 years, 4 months ago

Short Long
View Episode
Episode 321 ASCO24: CHAARTED-2 in prostate cancer - is the sequel as good as the original?
Episode 321 ASCO24: CHAARTED-2 in prostate cancer - is the sequel as good as the original?

Season 3 Episode 321

Christos Kyriakopoulos describes the outcome of this study, where cabazitaxel with abiraterone as combined with abiraterone alone in docetaxel refrac…

2 years, 4 months ago

Short Long
View Episode
Episode 320: Team Canada's entry for the Uromigos Cup
Episode 320: Team Canada's entry for the Uromigos Cup

Season 3 Episode 320

Danny Heng, Christian Kollmannsberger and Kala Sridhar answer questions in an attempt to get to Nashville and take on LA to win the Uromigos Cup.

2 years, 5 months ago

Short Long
View Episode
Episode 319: ASCO 2024: A Preview of GU Data
Episode 319: ASCO 2024: A Preview of GU Data

Season 3 Episode 319

What to see at the ASCO 2024 Annual Meeting, with Silke Gillessen.

2 years, 5 months ago

Short Long
View Episode
Episode 318: The Lancet Commission on prostate cancer: planning for a surge in cases
Episode 318: The Lancet Commission on prostate cancer: planning for a surge in cases

Season 3 Episode 318

Nick James discusses this paper, which covers broad issues in prostate cancer - including diagnosis and treatment with a focus on the future.

2 years, 5 months ago

Short Long
View Episode
Episode 317: AUA 2024 Preview with the AUA Secretary
Episode 317: AUA 2024 Preview with the AUA Secretary

Season 3 Episode 317

David Penson discusses highlights for the upcoming meeting. He articulates his excitement around the NMIBC data.

2 years, 5 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us